Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8600 Old Georgetown Rd
Bethesda, MD 20814Phone+1 301-896-3517Fax+1 301-493-4259
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1994 - 1997
University of AlbertaClass of 1994
Certifications & Licensure
MD State Medical License 1998 - 2026
FL State Medical License 1997 - 1998
MN State Medical License 1996 - 1998- American Board of Internal Medicine Hematology
Clinical Trials
- Gene Therapy for Chronic Granulomatous Disease Start of enrollment: 2006 Oct 30
- Donor Stem Cell Transplantation for Congenital Immunodeficiencies Start of enrollment: 2007 Jan 19
- Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers Start of enrollment: 2016 Oct 06
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPreclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous DiseaseAndrea Schejtman, Winston Vetharoy, Uimook Choi, Christine Rivat, Narda Theobald
Human Gene Therapy. 2021-05-06 - Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies.Elizabeth M. Kang
Current Allergy and Asthma Reports. 2021-03-05 - 1 citationsLow Plasma Gelsolin Concentrations in Chronic Granulomatous DiseaseJohn Audley, Emily F. Gliniewicz, Kol A. Zarember, Hanna S Hong, Gal Wald
Inflammation. 2021-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
